Type 1 diabetes trials in Finland

4 of 9 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

  Where

  Helsinki

  Age

  18 years to 99 years

  People

  24,000 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT05663515
• No phaseEnrolling by invitation
  FinnDiane LifeOne Study - Impact of Ageing on People With Type 1 Diabetes

  Where

  Helsinki

  Age

  65 years and over

  People

  400

  Run by

  Helsinki University Central Hospital

  See details and how to joinNCT07289204
• No phaseTaking people
  Noninvasive Evaluation of Fetal Hyperinsulinemia With Ultrasound Radiomics

  Where

  Turku

  Age

  18 years to 45 years

  People

  60

  Run by

  Turku University Hospital

  See details and how to joinNCT06343974
• No phaseTaking people
  TrialNet Pathway to Prevention of T1D

  Where

  Turku

  Age

  2 years to 45 years

  People

  75,000 worldwide

  Run by

  University of South Florida

  See details and how to joinNCT00097292